Research progress in the use of bifidobacteria for the treatment of colorectal cancer  

作　　者：Yu-Ting Zhao Zhi-Hui Cai Yu-Chen Yang 

机构地区：[1]Graduate School,Inner Mongolia Medical University,Hohhot 010017,China [2]Department of Medical Oncology,Inner Mongolia People’s Hospital,Hohhot 010017,China

出　　处：《Gastroenterology & Hepatology Research》2022年第3期30-33,共4页胃肠与肝病学杂志（英文）

基　　金：Medical and health Science and Technology Project of Inner Mongolia Autonomous Region Health Commission(No.202202031).

摘　　要：Colorectal cancer has high morbidity and mortality rates;therefore,developing new therapeutic drugs and methods for it is crucial.There is increasing evidence that intestinal flora plays a vital role in maintaining intestinal homeostasis and therefore,in the development of colorectal cancer.As such,therapeutic approaches using probiotics such as Bifidobacterium lactis to regulate intestinal flora are expected to represent a new treatment strategy for colorectal cancer.This article introduces and compares the development status of conventional therapies for colorectal cancer,primarily targeted therapy and immunotherapy,the relationship between intestinal flora and colorectal cancer,and the research and application of Bifidobacterium bifidum in colorectal cancer treatment to provide a reference for its clinical application.

关 键 词：colorectal cancer treatment intestinal flora BIFIDOBACTERIA 

分 类 号：R73[医药卫生—肿瘤]